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Tthe structure of the title compound, C15H24O5, has been
redetermined at 103 (2) K, with much improved precision.The
title compound was ﬁrst reported by Luo, Yeh, Brossi,
Flippen-Anderson & Gillardi [Helv. Chim. Acta (1984). 67,
1515–1522]. It is a derivative of the antimalaria compound
artemisinin and consists primarily of three substituted ring
systems fused together. A cyclohexane ring (with a distorted
chair conformation), is fused to a tetrahydropyran group (also
with a distorted chair conformation), and is adjacent to an
oxacycloheptane unit containing an endoperoxide bridge. This
gives the molecule a unique three-dimensional arrangement.
The crystal packing is stabilized by intermolecular C–H   O
and O–H   O interactions between an H atom from the
cyclohexane ring and an O atom from the endoperoxide
bridge, as well as between the hydroxyl H atom and an O atom
from a tetrahydropyran ring.
Related literature
For crystal structures of similar compounds, see: Flippen-
Anderson et al. (1989), Yue et al. (2006), Li et al. (2006); Karle
& Lin (1995); Brossi et al. (1988). For the biological activity of
artemisinin derivatives in vitro and in vivo, see: Li et al. (2001);
Yang et al. (1997); Grace et al. (1998); Maggs et al. (2000). For
endoperoxide sesquiterpene lactone derivatives, see: Venu-
gopalan et al. (1995); Wu et al. (2001); Saxena et al. (2003). For
the synthesis of artemisinin and its derivatives, see: Lui et al.
(1979); Liu (1980); Robert et al. (2001). For related literature,
see: Allen et al. (1987); Cremer & Pople (1975); Lisgarten et al.
(1998); Qinghaosu Research Group (1980); Shen & Zhuang
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Table 1
Hydrogen-bond geometry (A ˚ ,  ).
D—H   AD —H H   AD    AD —H   A
O5—H5   O2
i 0.84 1.95 2.7799 (19) 168
C5—H5A   O4
ii 1.00 2.38 3.381 (3) 175
Symmetry codes: (i) x þ 1
2; y þ 1
2; z þ 2; (ii) x þ 1;y;z.
Data collection: APEX2 (Bruker, 2006); cell reﬁnement: APEX2;
data reduction: SAINT (Bruker, 2006); program(s) used to solve
structure: SHELXS97 (Sheldrick, 1990); program(s) used to reﬁne
structure: SHELXL97 (Sheldrick, 1997); molecular graphics:
SHELXTL (Bruker, 2000); software used to prepare material for
publication: SHELXTL.
RJB acknowledges the Laboratory for the Structure of
Matter at the Naval Research Laboratory, Washington DC,
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Redetermination of dihydroartemisinin at 103 (2) K
J. P. Jasinski, R. J. Butcher, H. S. Yathirajan, B. Narayana and T. V. Sreevidya
Comment
Artemisinin and its derivatives, dihydroartemisinin, artemether, arteether and artesunate are antimalarial drugs which possess
bioactivity with less toxicity (Wu & Li, 1995). Artemisinin is isolated from the leaves of plant Artemisia annua (Qinghao).
It is a sesquiterpene lactone with an endoperoxide linkage. Artemisinin derivatives are more potent than artemisinin and are
active by virtue of the endoperoxide. Their activity against strains of the parasite that had become resistant to conventional
chloroquine therapy and the ability due to its lipophilic structure, to cross the blood brain barrier, it was particularly effective
for the deadly cerebral malaria (Shen & Zhuang, 1984). Because of their shorter life time and decreasing activity, they
are used in combination with other antimalarial drugs. The notable activity of artemisinin derivatives in vitro and in vivo
has been reported in literature (Li et al. 2001 & Yang et al. 1997). However, some derivatives of artimisinine showed
moderate cytotoxicity in vitro. The electronegativity and bulk of the substituents that attached to the aryl group plays an
insignificant role in cytotoxicity. The antimalarial activity and cytotoxicity of some sesquiterpenoids has been reported in
the literature (Venugopalan et al. 1995; Wu et al. 2001 and Saxena et al. 2003). The endoperoxide moiety present in these
compounds plays an important role in antimalarial activity. Its 1,2,4 trioxane ring is unique in nature. After being opened in
the plasmodium it liberates singlet oxygen and forms free radical which inturn produces oxidative damage to the parasites
membrane. Artemisinin is hydrophobic in nature and are partitioned into the membrane of the plasmodium. The structures
of the antimalarials dihydroqinghaosu, artemether and artesunic acid derived from qinghaosu were elaborated by 1H-NMR
spectroscopy, and supported with X-ray data have been reported (Luo et al. 1984). The crystal structure of an ether dimer
of deoxydihydroqinghaosu, a potential metabolite of the antimalarial arteether is reported (Flippen-Anderson et al. 1989).
The correlation of the crystal structures of diastereomeric artemisinin derivatives with their proton NMR spectra in CDCl3
is reported (Karle & Lin, 1995). The crystal structure of artemisinin is reported (Lisgarten et al. 1998). The crystal structure
of a dimer of α- and β-dihydroartemisinin (Yue et al. 2006) and that of 9,10-dehydrodeoxyartemisin is recently reported
(Li et al. 2006). The synthesis of artemisinin and its derivatives are described (Lui et al. 1979; Lui, 1980; Robert et al.
2001). The synthesis and antimalarial properties of arteether have been reported (Brossi et al. 1988). β-Arteether (AE) is an
endoperoxide sesquiterpene lactone derivative currently being developed for the treatment of severe, complicated malaria
caused by multidrug-resistant Plasmodium falciparum (Grace et al. 1998). β-Artemether (AM), the O-methyl ether prodrug
of dihydroartemisinin (DHA), is an endoperoxide antimalarial (Maggs et al. 2000). In view of the importance of the title
compound, (I) C15H24O5, as n antimalarial drug, this paper reports a redetermination of the crystal structure first reported
by Luo et al. (1984).
The six-membered cyclohexane ring (A, C1—C6) is a slightly distorted chair, with Cremer & Pople (1975) puck-
ering  parameters  Q,  θ  and  φ  of  0.553  (2)  Å,  4.8  (2)°  and  170  (3)°,  respectively.  The  tetrahydropyran  group  (D,
C1—C2—C12—C11—O2—C10) is also a slightly distorted chair configuration with puckering parameters Q, θ and φ
of 0.539 (2) Å, 2.7 (2)° and 227 (4)°, respectively. For an ideal chair θ has a value of 0 or 180°. Similar conforma-
tions for rings A and D were found in 9,10-dehydrodeoxyartemisinin (Shu-Hui Li et al. 2006). The seven-membered
ring B (C1/C6—C9/O1—C10) contains the important peroxy linkage [O3—O4 = 1.471 (2) Å]. The six-membered ring C
(O1—C9—O3—O4—C1—C10) which contains both an oxygen bridge and a peroxy bridge is best described by a twist-supplementary materials
sup-2
boat conformation with puckering parameters Q, θ and φ of 0.750 (2) Å, 85.26 (15)° and 96.58 (11)°, respectively. For
an ideal twist-boat conformation, θ and φ are 90° and (60n + 30)°, respectively. This conformation is consistent with both
9,10-dehydrodeoxyartemisinin (Li et al. (2006) and dihydroartemisinin (Qinghaosu Research Group, 1980).
Experimental
The title compound (C15H24O5)was obtained in the pure form from Strides Arco Labs, Mangalore, India. X-ray diffraction
quality crystals were grown from acetone-methylacetoacetate (1:1). (m.p.: 413 K).
Refinement
All H atoms were initially located in a difference Fourier map. The methyl H atoms were then constrained to an ideal
geometry with C—H distances of 0.98 Å and Uiso(H) = 1.5Ueq(C), but each group was allowed to rotate freely about its
C—C bond. All other H atoms were placed in geometrically idealized positions and constrained to ride on their parent atoms
with C—H distances in the range 0.98–1.00 Å and Uiso(H) = 1.17–1.22Ueq(C). The hydroxyl H was idealized with an O—H
distance of 0.84Å and Uiso(H) = 1.21Ueq(O). Because no strong anomalous scattering atoms are present, the Friedel pairs
were merged in the refinement.
Figures
Fig. 1. ORTEP view of dihydroartemisinine, (I), showing the atom numbering scheme and
50% probability displacement ellipsoids.
Fig. 2. The molecular packing for I viewed down the c axis. Dashed lines indicate C–H···O
and O–H···O intermolecular hydrogen bonds.
Dihydroartemisinin
Crystal data
C15H24O5 F000 = 616
Mr = 284.34 Dx = 1.271 Mg m−3
Orthorhombic, P212121
Mo Kα radiation
λ = 0.71073 Å
Hall symbol: P 2ac 2ab Cell parameters from 4650 reflections
a = 5.5910 (6) Å θ = 2.6–29.6ºsupplementary materials
sup-3
b = 14.1309 (14) Å µ = 0.09 mm−1
c = 18.8062 (19) Å T = 103 (2) K
V = 1485.8 (3) Å3 Needle, colorless
Z = 4 0.67 × 0.11 × 0.09 mm
Data collection
Bruker APEXII CCD area-detector
diffractometer
2475 independent reflections
Radiation source: fine-focus sealed tube 2130 reflections with I > 2σ(I)
Monochromator: graphite Rint = 0.044
T = 103(2) K θmax = 30.5º
φ and ω scans θmin = 1.8º
Absorption correction: multi-scan
(SADABS; Sheldrick, 1996) h = −5→7
Tmin = 0.940, Tmax = 0.992 k = −19→19
16573 measured reflections l = −26→26
Refinement
Refinement on F2 H-atom parameters constrained
Least-squares matrix: full
  w = 1/[σ2(Fo
2) + (0.0434P)2 + 0.5149P]
where P = (Fo
2 + 2Fc
2)/3
R[F2 > 2σ(F2)] = 0.038 (Δ/σ)max = 0.002
wR(F2) = 0.100 Δρmax = 0.37 e Å−3
S = 1.06 Δρmin = −0.22 e Å−3
2475 reflections Extinction correction: none
185 parameters
Primary atom site location: structure-invariant direct
methods
Secondary atom site location: difference Fourier map
Hydrogen site location: inferred from neighbouring
sites
Special details
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance mat-
rix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations
between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of
cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, convention-
al R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > 2sigma(F2) is used only for calculat-
ing R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice
as large as those based on F, and R– factors based on ALL data will be even larger.supplementary materials
sup-4
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)
x y z Uiso*/Ueq
O1 0.2493 (3) 0.35457 (10) 0.85285 (7) 0.0212 (3)
O2 0.1910 (3) 0.31049 (9) 0.96710 (6) 0.0187 (3)
O3 −0.1579 (3) 0.36796 (11) 0.87194 (7) 0.0250 (3)
O4 −0.1419 (3) 0.45439 (10) 0.91529 (7) 0.0229 (3)
O5 0.4123 (3) 0.34511 (9) 1.06918 (7) 0.0198 (3)
H5 0.4953 0.2959 1.0648 0.024*
C1 0.1042 (4) 0.47570 (13) 0.93520 (9) 0.0178 (4)
C2 0.0886 (4) 0.50052 (13) 1.01511 (9) 0.0195 (4)
H2A −0.0458 0.5467 1.0205 0.023*
C3 0.3158 (4) 0.55071 (13) 1.04118 (10) 0.0238 (4)
H3A 0.2942 0.5701 1.0914 0.029*
H3B 0.4523 0.5062 1.0390 0.029*
C4 0.3716 (5) 0.63737 (13) 0.99635 (10) 0.0269 (5)
H4A 0.5198 0.6674 1.0142 0.032*
H4B 0.2398 0.6837 1.0012 0.032*
C5 0.4035 (4) 0.61214 (13) 0.91802 (10) 0.0225 (4)
H5A 0.5412 0.5673 0.9140 0.027*
C6 0.1797 (4) 0.56209 (13) 0.88957 (9) 0.0195 (4)
H6A 0.0459 0.6089 0.8925 0.023*
C7 0.2078 (4) 0.53662 (14) 0.81060 (9) 0.0245 (4)
H7A 0.1986 0.5957 0.7825 0.029*
H7B 0.3697 0.5098 0.8035 0.029*
C8 0.0260 (5) 0.46691 (15) 0.78064 (10) 0.0269 (5)
H8A 0.0621 0.4558 0.7298 0.032*
H8B −0.1353 0.4955 0.7836 0.032*
C9 0.0230 (4) 0.37149 (15) 0.81945 (10) 0.0247 (4)
C10 0.2609 (4) 0.38836 (12) 0.92316 (9) 0.0163 (4)
H10A 0.4306 0.4051 0.9343 0.020*
C11 0.1826 (4) 0.32865 (13) 1.04225 (9) 0.0184 (4)
H11A 0.1159 0.2713 1.0663 0.022*
C12 0.0176 (4) 0.41122 (14) 1.05737 (9) 0.0200 (4)
H12A −0.1444 0.3922 1.0400 0.024*
C13 0.4636 (5) 0.70119 (16) 0.87466 (12) 0.0342 (6)
H13A 0.6048 0.7321 0.8950 0.051*
H13B 0.3278 0.7450 0.8760 0.051*
H13C 0.4967 0.6833 0.8253 0.051*
C14 −0.0293 (6) 0.28799 (17) 0.77187 (11) 0.0364 (6)
H14A −0.0491 0.2310 0.8010 0.055*
H14B 0.1039 0.2788 0.7387 0.055*
H14C −0.1765 0.2999 0.7451 0.055*
C15 −0.0068 (5) 0.42857 (16) 1.13739 (10) 0.0299 (5)
H15A −0.0695 0.3715 1.1604 0.045*
H15B −0.1169 0.4814 1.1456 0.045*
H15C 0.1503 0.4439 1.1574 0.045*supplementary materials
sup-5
Atomic displacement parameters (Å2)
U11 U22 U33 U12 U13 U23
O1 0.0215 (8) 0.0257 (6) 0.0163 (5) −0.0011 (6) 0.0014 (6) −0.0038 (5)
O2 0.0211 (7) 0.0181 (6) 0.0168 (6) −0.0022 (6) −0.0012 (6) 0.0004 (5)
O3 0.0209 (8) 0.0333 (7) 0.0208 (6) −0.0074 (6) −0.0017 (6) 0.0001 (6)
O4 0.0142 (7) 0.0317 (7) 0.0228 (6) 0.0013 (6) −0.0024 (5) −0.0013 (6)
O5 0.0172 (7) 0.0190 (6) 0.0232 (6) 0.0012 (5) −0.0047 (6) 0.0003 (5)
C1 0.0132 (9) 0.0230 (8) 0.0171 (8) 0.0018 (7) −0.0005 (7) −0.0016 (7)
C2 0.0197 (10) 0.0210 (8) 0.0180 (8) 0.0061 (8) 0.0005 (8) −0.0014 (6)
C3 0.0315 (12) 0.0206 (8) 0.0194 (8) −0.0016 (9) −0.0056 (9) 0.0010 (7)
C4 0.0385 (13) 0.0177 (8) 0.0245 (9) −0.0005 (9) −0.0043 (9) −0.0011 (7)
C5 0.0267 (11) 0.0185 (8) 0.0223 (8) −0.0003 (8) −0.0016 (8) 0.0033 (7)
C6 0.0196 (10) 0.0191 (8) 0.0198 (8) 0.0021 (7) −0.0019 (8) 0.0013 (7)
C7 0.0299 (12) 0.0257 (9) 0.0179 (8) −0.0017 (9) 0.0000 (8) 0.0036 (7)
C8 0.0293 (13) 0.0346 (11) 0.0168 (8) −0.0045 (10) −0.0052 (8) 0.0032 (8)
C9 0.0245 (11) 0.0323 (10) 0.0175 (8) −0.0066 (9) −0.0010 (8) −0.0005 (8)
C10 0.0165 (9) 0.0170 (7) 0.0156 (7) −0.0003 (7) −0.0006 (7) −0.0007 (6)
C11 0.0160 (9) 0.0230 (8) 0.0161 (7) −0.0023 (8) −0.0016 (7) 0.0020 (7)
C12 0.0169 (10) 0.0265 (9) 0.0165 (8) 0.0011 (8) 0.0016 (7) 0.0016 (7)
C13 0.0446 (15) 0.0275 (10) 0.0304 (10) −0.0116 (11) −0.0032 (11) 0.0058 (9)
C14 0.0470 (17) 0.0386 (12) 0.0234 (10) −0.0151 (12) −0.0042 (11) −0.0034 (9)
C15 0.0351 (14) 0.0370 (11) 0.0177 (9) 0.0037 (10) 0.0051 (9) −0.0001 (8)
Geometric parameters (Å, °)
O1—C10 1.407 (2) C6—C7 1.536 (3)
O1—C9 1.432 (3) C6—H6A 1.0000
O2—C10 1.431 (2) C7—C8 1.524 (3)
O2—C11 1.437 (2) C7—H7A 0.9900
O3—C9 1.414 (3) C7—H7B 0.9900
O3—O4 1.471 (2) C8—C9 1.533 (3)
O4—C1 1.457 (2) C8—H8A 0.9900
O5—C11 1.400 (2) C8—H8B 0.9900
O5—H5 0.8400 C9—C14 1.509 (3)
C1—C10 1.531 (3) C10—H10A 1.0000
C1—C2 1.546 (2) C11—C12 1.514 (3)
C1—C6 1.551 (3) C11—H11A 1.0000
C2—C3 1.535 (3) C12—C15 1.531 (3)
C2—C12 1.543 (3) C12—H12A 1.0000
C2—H2A 1.0000 C13—H13A 0.9800
C3—C4 1.519 (3) C13—H13B 0.9800
C3—H3A 0.9900 C13—H13C 0.9800
C3—H3B 0.9900 C14—H14A 0.9800
C4—C5 1.526 (3) C14—H14B 0.9800
C4—H4A 0.9900 C14—H14C 0.9800
C4—H4B 0.9900 C15—H15A 0.9800
C5—C6 1.533 (3) C15—H15B 0.9800supplementary materials
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C5—C13 1.537 (3) C15—H15C 0.9800
C5—H5A 1.0000
C10—O1—C9 113.35 (15) C7—C8—H8A 108.9
C10—O2—C11 116.08 (13) C9—C8—H8A 108.9
C9—O3—O4 108.29 (14) C7—C8—H8B 108.9
C1—O4—O3 111.82 (13) C9—C8—H8B 108.9
C11—O5—H5 109.5 H8A—C8—H8B 107.7
O4—C1—C10 109.63 (15) O3—C9—O1 108.65 (14)
O4—C1—C2 104.10 (15) O3—C9—C14 104.33 (18)
C10—C1—C2 111.04 (14) O1—C9—C14 107.5 (2)
O4—C1—C6 106.12 (15) O3—C9—C8 111.78 (19)
C10—C1—C6 113.38 (16) O1—C9—C8 110.25 (17)
C2—C1—C6 112.01 (15) C14—C9—C8 114.03 (16)
C3—C2—C12 115.21 (16) O1—C10—O2 105.60 (13)
C3—C2—C1 111.63 (17) O1—C10—C1 112.70 (14)
C12—C2—C1 109.25 (15) O2—C10—C1 112.21 (15)
C3—C2—H2A 106.8 O1—C10—H10A 108.7
C12—C2—H2A 106.8 O2—C10—H10A 108.7
C1—C2—H2A 106.8 C1—C10—H10A 108.7
C4—C3—C2 111.42 (17) O5—C11—O2 110.82 (16)
C4—C3—H3A 109.3 O5—C11—C12 111.27 (15)
C2—C3—H3A 109.3 O2—C11—C12 110.01 (15)
C4—C3—H3B 109.3 O5—C11—H11A 108.2
C2—C3—H3B 109.3 O2—C11—H11A 108.2
H3A—C3—H3B 108.0 C12—C11—H11A 108.2
C3—C4—C5 111.80 (16) C11—C12—C15 111.25 (16)
C3—C4—H4A 109.3 C11—C12—C2 112.14 (16)
C5—C4—H4A 109.3 C15—C12—C2 113.47 (17)
C3—C4—H4B 109.3 C11—C12—H12A 106.5
C5—C4—H4B 109.3 C15—C12—H12A 106.5
H4A—C4—H4B 107.9 C2—C12—H12A 106.5
C4—C5—C6 110.45 (18) C5—C13—H13A 109.5
C4—C5—C13 110.27 (16) C5—C13—H13B 109.5
C6—C5—C13 111.78 (17) H13A—C13—H13B 109.5
C4—C5—H5A 108.1 C5—C13—H13C 109.5
C6—C5—H5A 108.1 H13A—C13—H13C 109.5
C13—C5—H5A 108.1 H13B—C13—H13C 109.5
C5—C6—C7 111.22 (18) C9—C14—H14A 109.5
C5—C6—C1 113.09 (15) C9—C14—H14B 109.5
C7—C6—C1 112.24 (15) H14A—C14—H14B 109.5
C5—C6—H6A 106.6 C9—C14—H14C 109.5
C7—C6—H6A 106.6 H14A—C14—H14C 109.5
C1—C6—H6A 106.6 H14B—C14—H14C 109.5
C8—C7—C6 116.15 (18) C12—C15—H15A 109.5
C8—C7—H7A 108.2 C12—C15—H15B 109.5
C6—C7—H7A 108.2 H15A—C15—H15B 109.5
C8—C7—H7B 108.2 C12—C15—H15C 109.5
C6—C7—H7B 108.2 H15A—C15—H15C 109.5
H7A—C7—H7B 107.4 H15B—C15—H15C 109.5supplementary materials
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C7—C8—C9 113.55 (17)
C9—O3—O4—C1 −45.32 (18) O4—O3—C9—C14 −172.27 (16)
O3—O4—C1—C10 −15.82 (18) O4—O3—C9—C8 −48.58 (19)
O3—O4—C1—C2 −134.68 (13) C10—O1—C9—O3 −32.1 (2)
O3—O4—C1—C6 106.97 (15) C10—O1—C9—C14 −144.41 (16)
O4—C1—C2—C3 −164.53 (15) C10—O1—C9—C8 90.75 (18)
C10—C1—C2—C3 77.58 (19) C7—C8—C9—O3 96.3 (2)
C6—C1—C2—C3 −50.3 (2) C7—C8—C9—O1 −24.6 (2)
O4—C1—C2—C12 66.88 (19) C7—C8—C9—C14 −145.6 (2)
C10—C1—C2—C12 −51.0 (2) C9—O1—C10—O2 92.17 (17)
C6—C1—C2—C12 −178.90 (17) C9—O1—C10—C1 −30.7 (2)
C12—C2—C3—C4 179.84 (17) C11—O2—C10—O1 −178.37 (16)
C1—C2—C3—C4 54.5 (2) C11—O2—C10—C1 −55.2 (2)
C2—C3—C4—C5 −58.2 (3) O4—C1—C10—O1 56.06 (19)
C3—C4—C5—C6 56.9 (2) C2—C1—C10—O1 170.53 (16)
C3—C4—C5—C13 −179.1 (2) C6—C1—C10—O1 −62.3 (2)
C4—C5—C6—C7 179.67 (16) O4—C1—C10—O2 −63.01 (18)
C13—C5—C6—C7 56.5 (2) C2—C1—C10—O2 51.5 (2)
C4—C5—C6—C1 −53.0 (2) C6—C1—C10—O2 178.61 (14)
C13—C5—C6—C1 −176.14 (18) C10—O2—C11—O5 −67.1 (2)
O4—C1—C6—C5 163.26 (15) C10—O2—C11—C12 56.3 (2)
C10—C1—C6—C5 −76.35 (19) O5—C11—C12—C15 −60.2 (2)
C2—C1—C6—C5 50.3 (2) O2—C11—C12—C15 176.61 (17)
O4—C1—C6—C7 −69.9 (2) O5—C11—C12—C2 68.1 (2)
C10—C1—C6—C7 50.5 (2) O2—C11—C12—C2 −55.1 (2)
C2—C1—C6—C7 177.11 (18) C3—C2—C12—C11 −72.8 (2)
C5—C6—C7—C8 166.05 (18) C1—C2—C12—C11 53.8 (2)
C1—C6—C7—C8 38.2 (3) C3—C2—C12—C15 54.3 (2)
C6—C7—C8—C9 −58.4 (3) C1—C2—C12—C15 −179.07 (18)
O4—O3—C9—O1 73.30 (18)
Hydrogen-bond geometry (Å, °)
D—H···A D—H H···A D···A D—H···A
O5—H5···O2i 0.84 1.95 2.7799 (19) 168
C5—H5A···O4ii 1.00 2.38 3.381 (3) 175
Symmetry codes: (i) x+1/2, −y+1/2, −z+2; (ii) x+1, y, z.supplementary materials
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Fig. 1supplementary materials
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Fig. 2